Bladder Cancer Index (BCI)
TECHNOLOGY NUMBER: 2020-074

OVERVIEW
Health related quality of life measure for patients diagnosed with bladder cancer with emphasis on treatment related patient reported outcomes in the urinary, bowel and sexual domains
- Quality of life Measure
- Open Access - Creative Commons Attribution-NonCommercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0)
BACKGROUND
The Bladder Cancer Index (BCI) was developed by researchers at the University of Michigan to measure health related quality of life among men with bladder cancer. It represents an adaptation of the UCLA Prostate Cancer Index, modified to enhance sensitivity to therapy effects by increasing the number of prostate-targeted items to 50 (compared to 20 in the original UCLA-PCI).
ADDITIONAL DETAILS
REFERENCES:
Gilbert, S. M., Dunn, R. L., Hollenbeck, B. K., Montie, J. E., Lee, C. T., Wood, D. P., & Wei, J. T. (2010). Development and Validation of the Bladder Cancer Index: A comprehensive, disease specific measure of health related quality of life in patients with localized bladder cancer. The Journal of Urology, 183(5), 1764–1770. https://doi.org/10.1016/j.juro.2010.01.013
INTELLECTUAL PROPERTY:
(c) 2010 The Regents of the University of Michigan The Bladder Cancer Index (BC) is licensed under the Creative Commons Attribution-No Derivatives 4.0 International (CC BY-ND 4.0) License.
-
swap_vertical_circlemode_editInventor (7)Scott GilbertJohn WeiRod DunnDavid WoodCheryl LeeJames MontieBrent Hollenbeck
-
swap_vertical_circlecloud_downloadSupporting documents (1)Product brochureBladder Cancer Index (BCI).pdfAdditional files may be available once you've completed the transaction for this product. If you've already done so, please log into your account and visit My account / Downloads section to view them.